Praxis precision medicines provides corporate update and reports second quarter 2025 financial results

Radiant study with vormatrigine in focal onset seizure (fos) patients over eight weeks demonstrated 56.3% median reduction in seizure frequency from baseline, with 22% at 100% seizure reduction in last 28 days
PRAX Ratings Summary
PRAX Quant Ranking